What is the catalog number for Tifuvirtide?

The catalog number for Tifuvirtide is HY-P35433.

What sizes are available for Tifuvirtide?

Tifuvirtide is available in the following size(s): 1 Each.

Is Tifuvirtide in stock?

Tifuvirtide is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Tifuvirtide?

Tifuvirtide is manufactured by QuantiMol.

What is the estimated delivery time for Tifuvirtide?

Estimated delivery time for Tifuvirtide is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Tifuvirtide?

The safety data sheet for Tifuvirtide is available here: http://file.medchemexpress.com/batch_PDF/HY-P35433/.

Tifuvirtide

Tifuvirtide (T-1249) is a peptide human immunodeficiency virus type-1 (HIV-1) fusion inhibitor. Tifuvirtide is a synthetically designed hybrid retroviral envelope polypeptide. Tifuvirtide has antiretroviral activity. Tifuvirtide can be used for the research of HIV infection[1].

Product Specifications

CAS Number

251562-00-2

Product Name Alternative

T-1249

UNSPSC

12352209

Target

HIV

Type

Peptides

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/tifuvirtide.html

Solubility

10 mM in DMSO

Smiles

O=C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@H](O)C)C(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(N)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC3=CC=C(C=C3)O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC4=CNC5=CC=CC=C45)C(N[C@@H](C)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CC6=CNC7=CC=CC=C67)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC8=CNC9=CC=CC=C89)C(N[C@@H](CC%10=CC=CC=C%10)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC%11=CN(C(C)=O)C%12=CC=CC=C%11%12)N

Molecular Formula

C235H341N57O67

Molecular Weight

5036.55

References & Citations

[1] I van den Broek, et al. Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837 (1-2) :49-58.